Abstract
Sixteen patients with chronic CMO secondary to sarcoid, idiopathic uveitis, or cataract surgery (Irvine-Gass syndrome) were included in the study. The main inclusion criteria were presence of a visually significant form of CMO that had either failed topical anti-inflammatory treatment, or was deemed clinically severe enough to warrant systemic or periocular injections of corticosteroids primarily, and willingness to sign informed consent. The main exclusion criteria was refusal to consent to the procedure.

This publication has 0 references indexed in Scilit: